Model Estimation for Sars-Cov-2 Peak Contagion (Mespc): Brazil’s Case for the First and Second Wave

Autor: Asai G

With data for SARS-CoV-2 and with many countries entering the second wave of contagion required the improvement of the forecasting model, structuring its model to forecast the peak of the first and second contagion wave in Brazil. The Model Estimatio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8859ad75493c0541246ffc3455950e4

Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial.

Autor: Kawashima Y; Department of Pulmonary Medicine, Sendai Kousei Hospital, Sendai, Japan., Fukuhara T; Department of Respiratory Medicine, Miyagi Cancer Center, Natori, Japan., Saito H; Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan., Furuya N; Division of Respiratory Medicine, Department of Internal Medicine, St Marianna University School of Medicine, Kawasaki, Japan., Watanabe K; Department of Respiratory Medicine, Miyagi Cancer Center, Natori, Japan., Sugawara S; Department of Pulmonary Medicine, Sendai Kousei Hospital, Sendai, Japan., Iwasawa S; Department of Respirology, Chiba University, Chiba, Japan., Tsunezuka Y; Department of General Thoracic Surgery, Ishikawa Prefectural Central Hospital, Kanazawa, Japan., Yamaguchi O; Department of Respiratory Medicine, Saitama Medical University International Medical Center, Saitama, Japan., Okada M; Department of Surgical Oncology, Hiroshima University Hospital, Hiroshima, Japan., Yoshimori K; Clinical Cancer Center, Fukujuji Hospital, Tokyo, Japan., Nakachi I; Pulmonary Division, Department of Internal Medicine, Saiseikai Utsunomiya Hospital, Utsunomiya, Japan., Seike M; Department of Pulmonary Medicine and Oncology, Nippon Medical School, Tokyo, Japan., Azuma K; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University, Kurume, Japan., Kurimoto F; Department of Thoracic Oncology, Saitama Cancer Center, Saitama, Japan., Tsubata Y; Department of Internal Medicine, Division of Medical Oncology and Respiratory Medicine, Shimane University, Shimane, Japan., Fujita Y; Department of Respiratory Medicine, National Hospital Organization Asahikawa Medical Center, Asahikawa, Japan., Nagashima H; Division of Pulmonary Medicine, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japan., Asai G; Division of Medical Oncology, Aichi Cancer Center Aichi Hospital, Okazaki, Japan., Watanabe S; Department of Respiratory Medicine and Infectious Diseases, Niigata University Medical and Dental Hospital, Niigata, Japan., Miyazaki M; Department of Respiratory Medicine, Suita Municipal Hospital, Osaka, Japan., Hagiwara K; Division of Pulmonary Medicine, Department of Internal Medicine, Jichi Medical University, Shimotsuke, Japan., Nukiwa T; Tohoku University, Sendai, Japan., Morita S; Department of Biomedical Statistics and Bioinformatics, Kyoto University, Kyoto, Japan., Kobayashi K; Department of Respiratory Medicine, Saitama Medical University International Medical Center, Saitama, Japan., Maemondo M; Division of Pulmonary Medicine, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japan. Electronic address: maemondo-ma693@aioros.ocn.ne.jp.

Publikováno v: The Lancet. Respiratory medicine [Lancet Respir Med] 2022 Jan; Vol. 10 (1), pp. 72-82. Date of Electronic Publication: 2021 Aug 26.

Efficacy and toxicity of lurbinectedin in subsequent systemic therapy of extensive-stage small cell lung cancer: a meta-analysis.

Autor: Tang, Jiayi^1,2 (AUTHOR), Wang, Tianlei^1,2 (AUTHOR), Wu, Hongwei^1,2 (AUTHOR), Bao, Xinrui^1,2 (AUTHOR), Xu, Ke^1,2 (AUTHOR) xuke@cmc.edu.cn, Ren, Tao^1,2 (AUTHOR) rentao509@cmc.edu.cn

Publikováno v: BMC Cancer. 11/5/2024, Vol. 24 Issue 1, p1-13. 13p.

P2.14-52 The Results from Plasma EGFR Mutation Analysis in NEJ026 Study

Autor: Fukuhara, T., Saito, H., Furuya, N., Watanabe, K., Sugawara, S., Iwasawa, S., Tsunezuka, Y., Yamaguchi, O., Okada, M., Yoshimori, K., Nakachi, I., Gemma, A., Azuma, K., Kurimoto, F., Tsubata, Y., Fujita, Y., Nagashima, H., Asai, G., Watanabe, S., Miyazaki, M., Hagiwara, K., Nukiwa, T., Morita, S., Kobayashi, K., Maemondo, M.

Publikováno v: In Journal of Thoracic Oncology October 2019 14(10) Supplement:S850-S851

Evaluation of plasma EGFR mutation as an early predictor of response of erlotinib plus bevacizumab treatment in the NEJ026 study.

Autor: Fukuhara T; Miyagi Cancer Center, Natori, Japan., Saito H; Kanagawa Cancer Center, Yokohama, Japan., Furuya N; St. Marianna University School of Medicine, Kawasaki, Japan., Watanabe K; Miyagi Cancer Center, Natori, Japan., Sugawara S; Sendai Kousei Hospital, Sendai, Japan., Iwasawa S; Chiba University, Chiba, Japan., Tsunezuka Y; Ishikawa Prefectural Central Hospital, Kanazawa, Japan., Yamaguchi O; Saitama Medical University International Medical Center, Hidaka, Japan., Okada PM; Hiroshima University Hospital, Hiroshima, Japan., Yoshimori K; Fukujuji Hospital, Tokyo, Japan., Nakachi I; Saiseikai Utsunomiya Hospital, Utsunomiya, Japan., Gemma PA; Nippon Medical School, Tokyo, Japan., Azuma K; Kurume University, Kurume, Japan., Kurimoto F; Saitama Cancer Center, Ina, Japan., Tsubata Y; Shimane University, Shimane, Japan., Fujita Y; National Hospital Organization Asahikawa Medical Center, Asahikawa, Japan., Nagashima H; Division of Pulmonary Medicine, Allergy, and Rheumatology, Department of Internal Medicine, Iwate Medical University School of Medicine, 2-1-1, Idaidori, Yahaba-cho, Shiwa-gun, Iwate 028-3695, Japan., Asai G; Okazaki City Hospital, Okazaki, Japan., Watanabe S; Niigata University Medical and Dental Hospital, Niigata, Japan., Miyazaki M; Suita Municipal Hospital, Suita, Japan., Hagiwara PK; Jichi Medical University, Shimotsuke, Japan., Nukiwa PT; Tohoku University, Sendai, Japan., Morita PS; Kyoto University, Kyoto, Japan., Kobayashi PK; Saitama Medical University International Medical Center, Hidaka, Japan., Maemondo PM; Division of Pulmonary Medicine, Allergy, and Rheumatology, Department of Internal Medicine, Iwate Medical University School of Medicine, 2-1-1, Idaidori, Yahaba-cho, Shiwa-gun, Iwate 028-3695, Japan. Electronic address: maemondo-ma693@aioros.ocn.ne.jp.

Publikováno v: EBioMedicine [EBioMedicine] 2020 Jul; Vol. 57, pp. 102861. Date of Electronic Publication: 2020 Jul 03.